Kappa-Bifenthrin


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D000072660 Teratozoospermia PMID:32408700
MESH:D001008 Anxiety Disorders PMID:29775722
MESH:D001259 Ataxia PMID:19748519; PMID:9039463
MESH:D001930 Brain Injuries PMID:9039463
MESH:D002375 Catalepsy PMID:19748519
MESH:D003072 Cognition Disorders PMID:30102949
MESH:D003866 Depressive Disorder PMID:30978409
MESH:D004487 Edema PMID:31734314
MESH:D005334 Fever PMID:19748519
MESH:D008569 Memory Disorders PMID:30102949
MESH:D011041 Poisoning PMID:28456311; PMID:31276910
MESH:D011297 Prenatal Exposure Delayed Effects PMID:23994515
MESH:D012640 Seizures PMID:19748519
MESH:D014202 Tremor PMID:19748519; PMID:9039463
MESH:D015431 Weight Loss PMID:28251819; PMID:32408700
MESH:D017695 Soft Tissue Injuries PMID:31276910
MESH:D018476 Hypokinesia PMID:20019907
MESH:D053627 Asthenozoospermia PMID:32408700
MESH:D056486 Chemical and Drug Induced Liver Injury PMID:31734314
MESH:D064420 Drug-Related Side Effects and Adverse Reactions PMID:21854826

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.